JP2009538309A5 - - Google Patents

Download PDF

Info

Publication number
JP2009538309A5
JP2009538309A5 JP2009512121A JP2009512121A JP2009538309A5 JP 2009538309 A5 JP2009538309 A5 JP 2009538309A5 JP 2009512121 A JP2009512121 A JP 2009512121A JP 2009512121 A JP2009512121 A JP 2009512121A JP 2009538309 A5 JP2009538309 A5 JP 2009538309A5
Authority
JP
Japan
Prior art keywords
administration
compound
sterile
injectable
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009512121A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009538309A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/012270 external-priority patent/WO2007139816A2/en
Publication of JP2009538309A publication Critical patent/JP2009538309A/ja
Publication of JP2009538309A5 publication Critical patent/JP2009538309A5/ja
Pending legal-status Critical Current

Links

JP2009512121A 2006-05-23 2007-05-23 プロテインキナーゼのインヒビターとして有用なチオフェンカルボキサミド Pending JP2009538309A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80286706P 2006-05-23 2006-05-23
PCT/US2007/012270 WO2007139816A2 (en) 2006-05-23 2007-05-23 Thiophene-carboxamides useful as inhibitors of protein kinases

Publications (2)

Publication Number Publication Date
JP2009538309A JP2009538309A (ja) 2009-11-05
JP2009538309A5 true JP2009538309A5 (https=) 2010-07-01

Family

ID=38606563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009512121A Pending JP2009538309A (ja) 2006-05-23 2007-05-23 プロテインキナーゼのインヒビターとして有用なチオフェンカルボキサミド

Country Status (7)

Country Link
US (2) US8853244B2 (https=)
EP (2) EP2439206A1 (https=)
JP (1) JP2009538309A (https=)
CN (1) CN101484447A (https=)
AU (1) AU2007267986A1 (https=)
CA (1) CA2652816A1 (https=)
WO (1) WO2007139816A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2474546A1 (en) * 2006-01-23 2012-07-11 Vertex Pharmaceuticals Inc. Thiophene-carboxamides useful as inhibitors of protein kinases
WO2007120760A2 (en) * 2006-04-13 2007-10-25 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
WO2007139795A1 (en) * 2006-05-23 2007-12-06 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
WO2007139816A2 (en) 2006-05-23 2007-12-06 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
US9029411B2 (en) 2008-01-25 2015-05-12 Millennium Pharmaceuticals, Inc. Thiophenes and uses thereof
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
US9090601B2 (en) 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
WO2010090716A1 (en) 2009-01-30 2010-08-12 Millennium Pharmaceuticals, Inc. Heteroaryls and their use as pi3k inhibitors
JP5996532B2 (ja) 2010-07-15 2016-09-21 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 有害生物防除剤としての新規複素環式化合物
TW201217365A (en) 2010-08-11 2012-05-01 Millennium Pharm Inc Heteroaryls and uses thereof
WO2012021611A1 (en) 2010-08-11 2012-02-16 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
US8859768B2 (en) 2010-08-11 2014-10-14 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
TW201307309A (zh) 2010-10-13 2013-02-16 Millennium Pharm Inc 雜芳基化合物及其用途
CA2828578A1 (en) * 2011-03-04 2012-09-13 Lexicon Pharmaceuticals, Inc. Mst1 kinase inhibitors and methods of their use
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
WO2016161145A1 (en) * 2015-03-31 2016-10-06 Dana-Farber Cancer Institute, Inc. Stk4 inhibitors for treatment of hematologic malignancies
US11345681B1 (en) 2020-06-05 2022-05-31 Kinnate Biopharma Inc. Inhibitors of fibroblast growth factor receptor kinases

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255802B (it) 1992-08-07 1995-11-16 Luso Farmaco Inst Derivati imidazolici ad attivita' a ii antagonista
WO1997009325A1 (en) 1995-09-01 1997-03-13 Signal Pharmaceuticals, Inc. Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions
ES2167882T3 (es) 1997-04-24 2002-05-16 Dow Agrosciences Llc 3-(fenil sustituido)-5-(tienil o furil)-1,2,4-triazoles pesticidas.
DE19744026A1 (de) * 1997-10-06 1999-04-08 Hoechst Marion Roussel De Gmbh Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE69903992T2 (de) * 1998-04-15 2003-08-21 Pfizer Products Inc., Groton Heterocyclische Carboxamide
DK1123291T3 (da) 1998-10-23 2007-11-05 Dow Agrosciences Llc Fremgangsmåde til fremstilling af 3-(substitueret phenyl)-5-thienyl (eller furyl)-1,2,4-triazoler og hidtil ukendte mellemprodukter anvendt derved
US6605615B2 (en) 2000-03-01 2003-08-12 Tularik Inc. Hydrazones and analogs as cholesterol lowering agents
US7273868B2 (en) * 2000-04-28 2007-09-25 Tanabe Seiyaku Co., Ltd. Pyrazine derivatives
JP2005504014A (ja) 2001-06-08 2005-02-10 サイトビア インコーポレイテッド カスパーゼの活性化因子およびアポトーシスの誘導因子としての置換された3−アリール−5−アリール−[1,2,4]−オキサジアゾール類および類似体、並びにその使用法
JP2005509645A (ja) * 2001-10-30 2005-04-14 ファルマシア・コーポレーション 炎症処置用のヘテロ芳香族カルボキサミド誘導体
AU2003245380A1 (en) 2002-05-30 2003-12-19 King Pharmaceuticals Research & Development, Inc. Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
BR0313160A (pt) * 2002-08-08 2005-07-12 Smithkline Beecham Corp Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto
CN100364531C (zh) 2002-12-18 2008-01-30 西托维亚公司 3,5-二取代-[1,2,4]-二唑及类似物和其用途
JP2006522127A (ja) 2003-04-01 2006-09-28 スミスクライン ビーチャム コーポレーション イミダゾトリアジン化合物
US20050090529A1 (en) * 2003-07-31 2005-04-28 Pfizer Inc 3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
EP1685128A1 (en) 2003-10-16 2006-08-02 Smithkline Beecham Corporation Process for preparing benzimidazole thiophenes
JP2007519753A (ja) 2004-01-30 2007-07-19 スミスクライン ビーチャム コーポレーション 化合物
GB0402809D0 (en) 2004-02-09 2004-03-10 Glaxo Group Ltd Chemical compounds
WO2005095386A1 (en) * 2004-03-30 2005-10-13 Chiron Corporation Substituted thiophene derivatives as anti-cancer agents
AR049333A1 (es) 2004-04-02 2006-07-19 Vertex Pharma Azaindoles inhibidores de proteinquinasas rock y otras proteinas quinasas. composiciones farmaceuticas.
JP4935357B2 (ja) * 2004-11-08 2012-05-23 Msd株式会社 新規縮環イミダゾール誘導体
EP1831207B1 (en) 2004-12-17 2012-11-14 Amgen Inc. Aminopyrimidine compounds as plk inhibitors
MX2008003172A (es) 2005-09-06 2008-03-18 Smithkline Beecham Corp Proceso regioselectivo para la preparacion de bencimidazol-tiofenos.
EP2474546A1 (en) * 2006-01-23 2012-07-11 Vertex Pharmaceuticals Inc. Thiophene-carboxamides useful as inhibitors of protein kinases
WO2007120760A2 (en) 2006-04-13 2007-10-25 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
WO2007139795A1 (en) 2006-05-23 2007-12-06 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
WO2007139816A2 (en) 2006-05-23 2007-12-06 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases

Similar Documents

Publication Publication Date Title
JP2009538309A5 (https=)
CN105307498B (zh) 用于治疗眼病的组合物、制剂和方法
JP2018188478A (ja) 肝疾患を処置する方法
KR20170141757A (ko) 테트라하이드로나프티리디닐 프로피온산 유도체 및 이의 용도
JP2011517683A5 (https=)
JP2010504960A (ja) 水難溶性カンプトテシン誘導体のサブミクロンナノ粒子及びその製造方法
JP2010512397A (ja) アンサマイシン製剤およびその使用法
TWI564291B (zh) 一氧化氮生成調節劑
JP2015512398A (ja) Pfkfb2阻害剤および抗癌治療法としての使用方法
CN104387375A (zh) 硫化氢供体型异色满酮类衍生物、其制备方法及用途
JP2006515866A5 (https=)
CA3082786A1 (en) Stable compositions of pegylated carfilzomib compounds
TWI324066B (en) A pharmaceutical composition for inhibiting cell migration induced by an angiogenic factor
RU2554947C2 (ru) Соли азилсартана с органическими аминами, способ их получения и применение
WO2018183795A1 (en) Method of making tetrahydronaphthyridinyl nonanoic acid compounds
TW201139421A (en) Novel ep4 agonist
CA2508786A1 (en) Methods for inhibiting cancer and scar formation
JP2000086629A (ja) 新規な酸化窒素放出化合物
TW200533347A (en) Novel fused pyrazolyl compound
CN116650490A (zh) 化合物mt-1207在降低尿酸方面的应用
JP3193800B2 (ja) キサンチン誘導体を含有する筋損傷の予防および治療のための製剤
JP2023542964A5 (https=)
CN1879619A (zh) 癌症治疗
RU2658823C2 (ru) Аминовая соль и ее кристаллы
EP4552642A1 (en) Agent for reducing blood myostatin level